Morgan Stanley’s Genetron Holdings Limited ADS GTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,982
| Closed | -$7.98K | – | 8089 |
|
|
2024
Q1 | $7.98K | Sell |
1,982
-1,548
| -44% | -$5.94K | ﹤0.01% | 6778 |
|
|
2023
Q4 | $13K | Buy |
3,530
+3,005
| +572% | +$10.5K | ﹤0.01% | 6778 |
|
|
2023
Q3 | $1.28K | Hold |
525
| – | – | ﹤0.01% | 7201 |
|
|
2023
Q2 | $1.46K | Hold |
525
| – | – | ﹤0.01% | 7240 |
|
|
2023
Q1 | $1.65K | Sell |
525
-1,480
| -74% | -$4.74K | ﹤0.01% | 7272 |
|
|
2022
Q4 | $6.74K | Sell |
2,005
-274
| -12% | -$753 | ﹤0.01% | 7069 |
|
|
2022
Q3 | $5K | Sell |
2,279
-36,303
| -94% | -$122K | ﹤0.01% | 7270 |
|
|
2022
Q2 | $197K | Buy |
38,582
+940
| +2% | +$4.83K | ﹤0.01% | 5909 |
|
|
2022
Q1 | $247K | Sell |
37,642
-77,484
| -67% | -$848K | ﹤0.01% | 5799 |
|
|
2021
Q4 | $2.11M | Sell |
115,126
-6,708
| -6% | -$222K | ﹤0.01% | 4543 |
|
|
2021
Q3 | $5.06M | Buy |
121,834
+67,872
| +126% | +$3.13M | ﹤0.01% | 3689 |
|
|
2021
Q2 | $3.26M | Buy |
53,962
+3,139
| +6% | +$194K | ﹤0.01% | 4209 |
|
|
2021
Q1 | $3.27M | Buy |
50,823
+31,403
| +162% | +$2.16M | ﹤0.01% | 3847 |
|
|
2020
Q4 | $816K | Buy |
19,420
+18,089
| +1,359% | +$656K | ﹤0.01% | 4778 |
|
|
2020
Q3 | $48K | Buy |
+1,331
| New | +$51.2K | ﹤0.01% | 5741 |
|
Morgan Stanley's GTH Position: Q2 2024 in Review
Morgan Stanley sold out of Genetron Holdings Limited ADS (GTH) in Q2 2024, closing a stake of 1,982 shares — an estimated $7.98K sold.
Morgan Stanley first reported a position in GTH in Q3 2020 and held it in 15 quarters. The position peaked at $5.06M in Q3 2021. 0 funds tracked by Wall St. Rank hold GTH as of Q2 2024.
- Morgan Stanley reported no remaining Genetron Holdings Limited ADS position as of Q2 2024 after selling out during the quarter.
- Morgan Stanley sold 1,982 Genetron Holdings Limited ADS shares in Q2 2024, an estimated $7.98K.
- Morgan Stanley first reported a position in Genetron Holdings Limited ADS in Q3 2020 and held it in 15 quarters.
- Morgan Stanley's Genetron Holdings Limited ADS position peaked at $5.06M in Q3 2021.
- 0 funds tracked by Wall St. Rank held Genetron Holdings Limited ADS as of Q2 2024.
Based on Morgan Stanley's 13F filing for Q2 2024, filed 14 Aug 2024.